Table 5 Comparison of number of women who experienced adverse events
IPTp-SP | ISTp-AL | p-value | Total | |
|---|---|---|---|---|
n (%) | n (%) | n (%) | ||
Headache | 35 (15.3) | 34 (14.8) | 0.929 | 69 (15) |
Cough | 23 (10) | 17 (7.4) | 0.323 | 40 (8.7) |
Catarrh | 15 (6.6) | 15 (6.5) | 0.966 | 30 (6.5) |
Vomiting | 7 (3.1) | 9 (3.9) | 0.641 | 16 (3.5) |
Dizziness | 6 (2.6) | 10 (4.3) | 0.319 | 16 (3.5) |
Fever | 2 (0.9) | 10 (4.3) | 0.022 | 12 (2.6) |
Body pain | 5 (2.2) | 4 (1.7) | 0.699 | 9 (2.0) |
Itching | 4 (1.7) | 1 (0.4) | 0.172 | 5 (1.1) |
Nausea | 1 (0.4) | – | 0.337 | 1 (0.2) |
Rash | – | 1 (0.4) | 0.338 | 1 (0.2) |
Sleepiness | – | 1 (0.4) | 0.338 | 1 (0.2) |